ENVOY MEDICAL, INC. Cost of Revenue
ENVOY MEDICAL, INC. (COCH) reported Cost of Revenue of $278.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Cost of Sales
us-gaap:CostOfRevenue · last filed 2026-08-10
- ENVOY MEDICAL, INC. cost of revenue for the quarter ending 2026-06-30 was $278.00K, a 18.80% increase year-over-year.
- ENVOY MEDICAL, INC. cost of revenue for the quarter ending 2026-03-31 was $313.00K, a 38.50% increase year-over-year.
- ENVOY MEDICAL, INC. cost of revenue for the quarter ending 2025-06-30 was $234.00K.
- ENVOY MEDICAL, INC. cost of revenue for the quarter ending 2025-03-31 was $226.00K, a 47.71% increase year-over-year.
- ENVOY MEDICAL, INC. cost of revenue for fiscal 2024 was $742.00K, a 5.96% decline from fiscal 2023.
- ENVOY MEDICAL, INC. cost of revenue for fiscal 2023 was $789.00K.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 12 month |
|---|---|---|---|
| 2026-06-30 | $278.00K 10-Q · filed 2026-08-10 | $591.00K 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $313.00K POS AM · filed 2026-06-12 | ||
| 2025-06-30 | $234.00K 10-Q · filed 2026-08-10 | $460.00K 10-Q · filed 2026-08-10 | |
| 2025-03-31 | $226.00K POS AM · filed 2026-06-12 | ||
| 2024-12-31 | $742.00K 10-K · filed 2025-03-31 | ||
| 2024-03-31 | $153.00K 10-Q · filed 2025-05-01 | ||
| 2023-12-31 | $789.00K 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| ENvue Medical, Inc. (FEED) | United States | $0.011B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| Bone Biologics Corp (BBLG) | United States | $0.001B | |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |